Top compounds associated with response to ERVK3-1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA BRD8958 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA elocalcitol CTRPv2 pan-cancer AAC -0.038 0.3
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC -0.048 0.3
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.051 0.3
mRNA etomoxir CTRPv2 pan-cancer AAC -0.041 0.3
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC 0.042 0.3
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC 0.055 0.3
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.036 0.3
Download CSV